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Abstract
Background: A decade ago, the Institute for Healthcare Improvement pioneered a quality improvement (QI)
campaign, leveraging organizational and personal social networks to disseminate new practices. There have been
few rigorous studies of the QI campaign approach.
Methods: Project JOINTS (Joining Organizations IN Tackling SSIs) engaged a network of state-based organizations
and professionals in a 6-month QI campaign promoting adherence to three new evidence-based practices known
to reduce the risk of infection after joint replacement. We conducted a cluster-randomized trial including ten states
(five campaign states and five non-campaign states) with 188 hospitals providing joint replacement to Medicare.
We measured adherence to the evidence-based practices before and after the campaign using a survey of surgical
staff and a difference-in-difference design with multivariable adjustment to compare adherence to each of the
relevant practices and an all-or-none composite measure of the three new practices.
Results: In the campaign states, there were statistically significant increases in adherence to the three new
evidence-based practices promoted by the campaign. Compared to the non-campaign states, the relative increase
in adherence to the three new practices in the campaign states ranged between 1.9 and 15.9 percentage points,
but only one of these changes (pre-operative nasal screening for Staphylococcus aureus carriage and decolonization
prior to surgery) was statistically significant (p < 0.05). On the all-or-none composite measure, adherence to all three
evidence-based practices increased from 19.6 to 37.9% in the campaign states, but declined slightly in the
comparison states, yielding a relative increase of 23 percentage points (p = 0.004). In the non-campaign states,
changes in adherence were not statistically significant.
Conclusions: Within 6 months, in a cluster-randomized trial, a multi-state campaign targeting hospitals and
professionals involved in surgical care and infection control was associated with an increase in adherence to
evidence-based practices that can reduce surgical site infection.
* Correspondence: es@cmwf.org
1RAND Corporation, Santa Monica, CA, USA
2Division of General Medicine and Primary Care, Brigham and Women’s
Hospital, Boston, MA, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Schneider et al. Implementation Science  (2017) 12:51 
DOI 10.1186/s13012-017-0579-7
Background
Improving the quality and safety of care is a key national
objective in the United States. The Affordable Care Act of
2010 encourages the use of evidence-based practices and
innovative delivery models to drive quality improvement
(QI). Several methods, including academic detailing, activa-
tion of opinion leaders, and QI collaboratives, have been
shown in the past to improve health care quality [1–3].
Nevertheless, most efforts to accelerate the widespread
improvement through the use of new evidence-based
clinical practices have fallen short of expectations. Im-
provement projects often take substantial time and
organizational resources and may not succeed despite sev-
eral iterations. The use of academic detailing techniques
and mobilization of opinion leaders can be difficult to bring
to scale. QI collaboratives may be inefficient for rapidly
spreading new practices, and studies of collaboratives have
produced mixed results about the components essential for
success [3]. These uncertainties may give pause to organiza-
tions weighing whether to invest in a collaborative [4].
A decade ago, the Institute for Healthcare Improve-
ment (IHI) pioneered a potentially more efficient and ef-
fective model for engaging organizations in making
evidence-based changes to practice: the QI campaign.
First applied in IHI’s 100,000 Lives Campaign [5] be-
tween 2004 and 2006 and the 5 Million Lives Campaign
(designed to reduce adverse events in hospitals) [6] be-
tween 2006 and 2008, the model used several political
campaign techniques to achieve improvement. These in-
cluded targeted messages and communication strategies,
a “whistlestop tour,” “mentor” hospitals, and easily access-
ible expert faculty and campaign materials (such as prac-
tical “How-to Guides”) [7]. To leverage peer and social
network effects, the model sought endorsement and co-
messaging by relevant professional societies. IHI organized
a “Rapid Spread Network” (RSN), a volunteer network of
state-level organizations or “nodes” (e.g., state hospital
associations and CMS-sponsored quality improvement
organizations) to facilitate recruitment of local organiza-
tions and professionals and motivate their pursuit of the
campaign’s improvement goals [8, 9]. Several communica-
tion strategies such as regular calls with the node organi-
zations, an “office hours” function, and expert speakers
amplified the improvement messages generated by IHI.
Randomized controlled studies of IHI-style campaigns
have not been performed. The available evidence on
campaigns is incomplete and somewhat controversial
[10]. A comparison of expected versus observed hospital
mortality before and after the 100,000 Lives Campaign
suggested a reduction of more than 100,000 in-hospital
deaths relative to a projected number of deaths, but a for-
mal independent evaluation was not performed. The 5
Million Lives Campaign did not include measures of ad-
verse events, making it difficult to evaluate its effectiveness
in reducing harm to hospitalized patients. Other national
initiatives that included some features of campaigns (such
as the Get With the Guidelines stroke, heart failure, and
acute myocardial infarction initiatives) lacked control
groups, leaving uncertainty about how much improvement
was attributable to these initiatives [11, 12].
In 2011, IHI designed a new campaign to accelerate
uptake of evidence-based practices that had been shown
to prevent surgical site infections (SSI) associated with
hip and knee arthroplasty. Project JOINTS (Joining Or-
ganizations IN Tackling SSIs) was a multi-faceted, disci-
plined initiative that used the Rapid Spread Network
(defined above), methods, and tools developed during
previous IHI campaigns to influence orthopedic prac-
tices and hospitals performing hip and knee arthroplasty
[13]. Rather than launch nationally as other campaigns
have done, Project JOINTS was introduced in a cluster-
randomized fashion to enable a rigorous, independent
evaluation of its efficacy in promoting uptake of new
evidence-based practices.
Methods
Overview
We hypothesized that Project JOINTS would accelerate the
take-up of evidence-based infection prevention practices.
The network theory predicts both direct and indirect effects
of a campaign. Some local hospital leaders and clinicians
will participate directly in IHI campaign activities and adopt
the new evidence-based practices while others will become
aware of the practices indirectly through peers in the same
community or state. Because a campaign relies on indirect
transmission through social networks, the control group in
a randomized control trial of a campaign must be geo-
graphically distinct to avoid cross-contamination.
For Project JOINTS, the evaluation team designed a
state-level cluster-randomized trial involving five geo-
graphically distinct pairs of states selected and matched
on characteristics described below. One state from each
pair as selected at random to receive the 6-month Project
JOINTS campaign (the other state served as a matched
control). To measure changes in the relevant evidence-
based practices, RAND conducted a survey of staff partici-
pating in orthopedic surgery in all ten states before and
after Project JOINTS. The project was reviewed and ap-
proved by the RAND Institutional Review Board.
Intervention
A campaign is based on three main pillars: (1) the evi-
dence supporting new clinical practices that improve care;
(2) the evidence that bundling such practices can improve
uptake; [14] and (3) the theory underlying the actions that
make up the campaign. The three new evidence-based
practices not consistently applied to orthopedic surgical
patients prior to 2010 were as follows:
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1. Screen patients for nasal Staphylococcus aureus (SA)
carriage and decolonize SA carriers with 5 days of
intranasal mupirocin and CHG bathing (minimum
three consecutive days of daily use) in the days
immediately preceding surgery [15, 16]
2. Instruct patients, regardless of SA carriage, to bathe
or shower with chlorhexidine gluconate (CHG) for
at least 3 days before surgery [17–19]
3. Use an alcohol-containing antiseptic agent for
pre-operative skin preparation [20, 21]
Project JOINTS built on the notion of bundling [14].
IHI designed and encouraged implementation of a five-
component “enhanced” SSI prevention bundle including
the three new evidence-based practices above and two
well-established Surgical Care Improvement Program
(SCIP) practices (Table 1).
The campaign’s design reflected the previously de-
scribed campaign theory [8, 9]. IHI recruited state orga-
nizations from the RSN developed during the 100,000
Lives and 5 Million Lives Campaigns. The state organi-
zations reached out to hospitals in their states inviting
them to participate in the campaign, disseminating in-
formation about the campaign and its evidence-based
practices, and assisting IHI in publicizing activities de-
scribed below and in a prior publication [13].
IHI developed a logic model summarizing how cam-
paign activities were designed to achieve specified goals
(Additional file 1). This model was refined in collaboration
with the evaluation team to inform its selection of evalu-
ation measures. IHI developed intervention materials (in-
cluding a “How-to Guide,” evidence reviews, a summary
of the “business case” for the interventions to prevent
SSIs, and tip sheets for surgeons and other providers, and
patients and families), created and maintained a project
website and email listserv, and offered a range of learning
opportunities (including webinar calls, faculty-led office
hours, and town hall meetings). Hospital and practice staff
who participated in Project JOINTS (typically quality or
safety improvement leaders and staff with oversight of in-
fection prevention) received access to a password-
protected IHI website maintained by IHI.
In addition to SSI prevention in hip and knee arthro-
plasty, the Project JOINTs “How-To Guide” also ad-
dressed important elements of the “Model for
Improvement,” developed by Associates in Process
Improvement [22] and later adapted by IHI for use in its
campaigns. These elements included (1) the development
of a QI plan (including explicit aims and a measurement
framework); (2) small-scale tests of change (“PDSA cy-
cles”) to refine implementation approaches through itera-
tive learning; and (3) reliance on multi-disciplinary
implementation teams. To enhance credibility with clini-
cians, IHI collaborated with relevant professional organi-
zations, recruiting faculty from the American Academy of
Orthopedic Surgeons (AAOS) and the American Associ-
ation of Hip and Knee Surgeons (AAHKS) and obtaining
endorsement from the AAHKS.
Table 1 Five bundle components of Project JOINTS and the corresponding measures of evidence-based practices (in italics)a
Bundle component/measures Evidence/rationale for inclusion
New evidence-based infection control practices
1. Nasal screening and decolonization Screen patients for SA carriage and decolonize SA carriers with 5 days
of intranasal mupirocin [15, 16] because SA nasal colonization has been
shown to be associated with an increased risk for SSI1.a. Pre-operative nasal screening for Staphylococcus
aureus (SA) carriage
1.b. Intranasal mupirocin prescribed for methicillin-resistant
S. aureus (MRSA) carriers
1.c. Intranasal mupirocin prescribed for methicillin-resistant
S. aureus (MRSA) carriers
2. Chlorhexidine bathing 3 or more times pre-operatively Instruct patients to bathe or shower with chlorhexidine gluconate
(CHG) for at least 3 days before surgery [17–19] to reduce bacterial
colonization of the skin prior to surgery (regardless of SA carriage)
3. Alcohol-containing antiseptic used to prepare skin in
operating room
Use an alcohol-containing antiseptic agent for pre-operative skin
preparation [20, 21] because the use of alcohol in addition to a
long-acting antiseptic agent provides superior protection against SSIs
Previously promoted infection control practices from the Surgical Care Improvement Program (SCIP)
4. Peri-operative intravenous antibiotics SCIP practice 1
4.a. Timely receipt of prophylactic intravenous antibiotics
4.b. Peri-operative intravenous vancomycin for MRSA carriers
5. Appropriate hair removal technique (not razor) SCIP practice 2
aFor each infection control practices, respondents answered the following question: “Thinking about the patients undergoing hip and knee surgery whose care
you are involved in, to the best of your knowledge, estimate how frequently each of the following processes occurs for those patients who do not have any
contra-indications.” Response options were percentages from 0 to 100% in 10% increments and “do not know”
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Measuring adherence to evidence-based practices used to
prevent surgical site infection
To measure adherence to the evidence-based practices
used to prevent surgical site infection in the study hospi-
tals, RAND’s evaluation team developed a written survey
that could be completed by front-line professionals in-
volved in the direct care of patients (orthopedic sur-
geons, nurses, and operating room staff ); this survey was
administered before and after the Project JOINTS cam-
paign. Table 1 describes the approach to the primary study
outcomes and their associated survey questions. The
questions addressed three actions (or subcomponents)
constituting the nasal screening and decolonization
process (new practice 1): screening for SA (1.a.); mupiro-
cin nasal decolonization for methicillin-resistant SA
(MRSA) (1.b.) and mupirocin nasal decolonization for
methicillin-sensitive SA (MSSA) (1.c.). It included a ques-
tion on skin decolonization using CHG (new practice 2)
and a question on alcohol-containing antiseptic in the op-
erating room (new practice 3). Respondents were asked to
indicate the frequency of use of each practice among pa-
tients undergoing hip or knee arthroplasty. Response op-
tions ranged from 0 to 100% in 10% increments and a “do
not know” option. The survey separated practices 1 and 2,
but these may not be effective if not used together.
The survey also included questions on evidence-based
practices previously promoted by an established SSI pre-
vention program (the Surgical Care Improvement Program
or SCIP): a question about initiation of peri-operative
intravenous antibiotics within the appropriate time interval
prior to the start of arthroplasty (4.a.), a question about the
use of intravenous vancomycin for prophylaxis for patients
known to be MRSA carriers (4.b.), and a question on the
use of appropriate hair removal techniques (5). Project
JOINTS reinforced the use of these previously promoted
practices. In addition, to evaluate partial adherence to new
practices, the survey included a question about the use of
chlorhexidine bathing one or two times preoperatively ra-
ther than the three times recommended by Project
JOINTS [23]. The pre- and post-intervention surveys con-
tained a question about the respondent’s awareness of each
of the short list of active and recent QI projects, including
Project JOINTS.
The baseline survey (but not the follow-up survey) in-
cluded questions about factors that might affect the re-
sponsiveness of an organization to a QI intervention.
These questions, adapted from previous patient safety
surveys, addressed barriers to changing SSI prevention
protocols, allowed the respondent to grade the pre-
operative and surgical units for their performance on pa-
tient safety generally, and asked the respondent to rate
those units on their culture of excellence in QI [24].
Items were included to assess the hospital’s management
support for various patient safety activities, the use of
temporary staff, and staff turnover. It included questions
about respondent characteristics including type of staff
position and number of hours worked each week.
Hospital data and multistage sampling approach
RAND researchers obtained hospital characteristics from
the FY 2011 American Hospital Association data including
hospital ownership, affiliation with a hospital system/chain,
teaching status (member of the Council of Teaching
Hospitals), presence of a residency program, rural location,
and number of beds. Hip and knee replacement volumes
were based on 2009 Medicare Hospital Compare data.
Starting with organizations in 36 states that had partic-
ipated in previous IHI campaigns, IHI staff identified 18
states that had state-level organization leaders willing to
assist with Project JOINTS and willing to be randomized
to either beginning Project JOINTS within the year
(intervention) or waiting for a year to start Project
JOINTS after it was opened to other states (control).
From these 18 states, RAND researchers selected ten
states that had a minimum of 20 hospitals performing
hip and knee arthroplasty and could be sorted into five
pairs that were relatively well matched on (1) the num-
ber of hospitals performing at least 100 hip and knee
arthroplasties for Medicare beneficiaries each year
(based on 2009 CMS Compare data), (2) whether the
state required reporting of serious adverse events, and
(3) whether the state had non-payment policy for serious
reportable events. After the five state pairs were identi-
fied, one state was selected at random from each pair to
initiate Project JOINTS while the other served as a con-
trol. IHI staff contacted the state organization leader of
the intervention states to confirm the start date of the
campaign and the control states to express interest in
starting the campaign after the end of the trial.
Based on power calculations, accounting for the num-
ber of respondents per hospital, two-stage response
rates, the clustering of respondents by hospital, and the
correlation between baseline and follow-up surveys, we
estimated that a starting sample of approximately 1200
(6 respondents times 200 hospitals) would yield a final
sample with 80% power to detect an eight percentage
point change from an assumed baseline bundle adher-
ence rate of 40%. RAND researchers selected 20 hospi-
tals at random from among all hospitals in each state
that performed a minimum of 100 hip or knee arthro-
plasties for Medicare beneficiaries. In the two smallest
states, all hospitals meeting the inclusion criteria were
included. Members of the research team contacted each
selected hospital to request a list of surgeons, nurses,
and other staff involved in direct care of patients under-
going hip or knee arthroplasty, supplementing these lists
with directory searches for orthopedic surgical practices
affiliated with each hospital. From each of these hospital
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lists, six staff members were selected at random for in-
clusion in the staff survey sample.
Survey data collection
Beginning in February 2012, RAND’s Survey Research
Group sent all sampled staff members both mail and email
invitations to complete the baseline version of the survey
either by mail or via a website along with an offer of a $50
gift card incentive. Weekly reminders were sent to non-
responders by email or postcard, followed by a second copy
of the survey and up to ten phone prompts. In October
2012, after the 6-month Project JOINTS intervention, the
post-intervention version of the survey was sent to all sam-
pled individuals from hospitals with at least one respondent
to the baseline survey using the same follow-up protocol as
was used the baseline survey. The individual response rate
to the baseline survey was 41.2%, and response rate for the
follow-up survey was 51.6%.
Analysis
We excluded respondents who failed to answer the first
item on the survey (“In your staff position, do you typic-
ally have direct interaction or contact with patients?”)
and those who had missing or “do not know” responses
to six or more of the eight questions used as study out-
comes. We excluded hospitals that lacked a valid survey
response in both the pre-intervention and post-
intervention periods. Using survey data, we compared
the characteristics of individual respondents in campaign
and non-campaign states. Using the 2011 AHA data,
2009 Hospital Compare data, and baseline survey re-
sponse data listed above, we compared the hospital char-
acteristics in the campaign and the non-campaign states.
To measure the effect of the campaign, we used an
intention-to-treat approach, estimating the impact of being
located in a campaign state (vs. non-campaign state) using
a respondent-level analysis. The dependent variables were
pre-specified as the respondent-level reported percentage
adherence to each of the evidence-based components of
the SSI reduction bundle and an all-or-none composite cal-
culated as the percentage of respondents reporting >90%
adherence by the hospital to all three new evidence-based
components of the SSI reduction bundle. The stringent all-
or-none and >90% adherence criteria were selected to
measure whether the campaign drove highly-reliable adop-
tion of the entire package of evidence-based practices.
To account for potential confounding between the study
outcomes and residual non-random allocation of respond-
ent and hospital characteristics that can occur despite
cluster-randomization, we adjusted for these characteris-
tics at baseline using a hierarchical model. The model in-
cluded a state and a hospital level random effect for each
of the dependent variables, within a doubly robust method
for adjustment, calculating and using propensity score
weights [25, 26]. The goal was to make the distributions of
the respondent characteristics from the non-campaign
states resemble the distribution characteristics of the re-
spondents from the campaign states. The hospital mean
scores on baseline survey responses for patient safety
scales (management support for patient safety, teamwork
across units, handoffs and transitions) were also entered
into the models.
The propensity score weights were estimated (in the
TWANG package in R [27]) using both hospital and re-
spondent characteristics. Hospital characteristics included
ownership, affiliation with a hospital system, membership in
the counsel of teaching hospitals (COTH), residency pro-
gram, rural location, number of beds, 2013 Medicare volume
of hip and knee replacement surgeries, and the hospital
mean values of each of the three patient safety scales from
the survey. Individual respondent characteristics included
professional position (surgeon; physician assistant (PA)/nurse
practitioner (NP); other), whether the staff member had dir-
ect contact with patients, the type of surgical involvement
(pre-operative contact only; peri-operative contact only; both
pre-and peri-operative contact), years in the current specialty
or profession, years in current hospital, years in the current
unit, hours worked per week (less than 20; 20–39; 40+), and
a flag assigned if the individual had missing/do not know re-
sponses to three or more of the study outcomes.
We performed a difference-in-difference analysis for
each study outcome comparing the change from baseline
to post-intervention in campaign states and matched non-
campaign states. Each outcome was regressed on the main
effects for intervention (1 = intervention state; 0 = control
state) and time period (1 = post-intervention, 0 = base-
line). An interaction term including both the intervention
and time period variables was used to test the effect of the
intervention. Accounting for baseline differences allows us
to account for unmeasured differences between campaign
and non-campaign sites that are constant over time. Each
“frequency of use” study outcome (ranging 0 to 100% in
10% increments) was modeled linearly. The dichotomous
variable representing the all-or-none composite (at least
90% use of all evidence-based practices) was modeled
using a logistic regression. We included matched pair
blocks as fixed effects to account for the matching of
states. Potential confounders were included as fixed ef-
fects. To ease interpretation, we calculated the least-
squares means (LS-means) from the models. In this pro-
cedure, each model was used to predict the expected value
at baseline and follow-up in the intervention and control
states with all other fixed effects set to their mean values.
Results
After exclusions, 165 of the 188 sampled hospitals (88%)
had at least one valid survey response in both the base-
line and post-intervention time periods. Despite the
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state-level matched pairs, respondents in the campaign
and non-campaign states differed in professional pos-
ition, the length of time in specialty or profession, and
the length of time working within the hospital and unit,
but not in the proportions involved in pre-operative and
peri-operative care or the number of hours worked in
the hospital each week (Table 2). Study hospitals in the
campaign and non-campaign states were relatively simi-
lar on baseline characteristics including the average
number of respondents per hospital, the volume of hip
and knee arthroplasties for Medicare beneficiaries, own-
ership, affiliation with hospital networks, urban vs. rural
location, teaching status, and number of beds (Table 3).
Hospitals were similar also on reported measures of
quality and safety culture including management support
for patient safety, teamwork across units, and transitions
and handoffs.
Table 4 presents the main results after adjustment. In
the campaign states, adherence to the three new
evidence-based practices included in Project JOINTS in-
creased and was statistically significant. Comparing the
adherence change in campaign states to the adherence
change in non-campaign states (difference-in-difference),
the increase in adherence to the three new evidence-
based practices ranged between 1.9 and 15.9 percentage
points. Only the increase in adherence to the first of the
three new practices (nasal screening and decolonization
prior to surgery captured by three component measures)
was statistically significant (p < 0.05). In the non-campaign
states, none of the changes in adherence was statistically
significant. By chance, baseline adherence was higher in
non-campaign states than in campaign states on four of
the five measures of the new bundle components. Baseline
adherence to the measures previously featured in the SCIP
program (timely receipt of prophylactic antibiotics,
Table 2 Characteristics of survey respondents at baseline (n = 549)
Campaign
states
Non-campaign
states
n = 235 n = 314
% pa
Staff position <0.001
Surgeon 73.9 55.8
Physician assistant/nurse
practitioner
13.7 9.6
Otherb 12.4 34.6
Surgical involvement 0.65
Pre-operative and
peri-operative
77.7 74.4
Peri-operative only 19.3 21.8
Pre-operative only 3.0 3.9
Years working in current specialty or profession 0.012
Less than 6 years 14.1 22.6
6 to 10 years 16.2 19.4
More than 10 years 69.7 58.0
Years working in this hospital <0.001
Less than 6 years 23.0 38.8
6 to 10 years 20.4 20.2
More than 10 years 56.5 41.0
Years working in current unit 0.003
Less than 6 years 27.8 40.5
6 to 10 years 20.7 21.4
More than 10 years 51.5 38.2
Number of hours per week worked in this hospital 0.13
Less than 20 35.5 35.4
20–39 29.5 36.6
40 or more 35.0 28.0
aMantel-Hanzel chi-square test; italics indicate p<0.05
bOther categories included registered nurses, licensed vocational nurses,
licensed practical nurses, and surgical technicians
Table 3 Baseline characteristics of sampled hospitals in
campaign and non-campaign states
Campaign
states (n = 5)
Non-campaign
states (n = 5)
Number of hospitals n = 78 n = 95 p
Respondents per hospital
(mean, range)
2.33 (1, 6) 2.45 (1, 6)
Mean (S.D.)
Medicare hip/knee replacement
procedure volume (2009)
250.1 (130.7) 270.4 (188.9) 0.42
N (%)
Ownership 0.66
Nonprofit 67 (85.7) 76 (80.0)
For profit 6 (7.8) 11 (11.6)
Public 5 (6.5) 8 (8.4)
Part of hospital system/chain 55 (71.4) 68 (71.6) 0.98
Teaching status
Member of Council of
Teaching Hospitals (COTH)
6 (7.8) 14 (14.7) 0.23
Residency program 26 (33.8) 44 (46.3) 0.12
Located outside an MSA 16 (20.8) 12 (12.6) 0.21
Mean (S.D.)
Number of beds 270.5 (168.5) 280.5 (185.1) 0.72
Hospital quality and safety culturea
Management support for
patient safety
77.4 (24.3) 78.1 (24.5) 0.85
Teamwork across units 67.3 (27.0) 68.6 (26.5) 0.76
Handoffs and transitions 54.4 (31.2) 55.2 (32.4) 0.86
aQuestions adapted from prior surveys of quality and patient safety
culture [24]
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intravenous vancomycin for patients with MRSA, and ap-
propriate hair removal) exceeded 94% in both campaign
and non-campaign states.
On the all-or-none composite measure, the reported
hospital adherence to all measures of the three new
evidence-based bundle components increased from 19.6
to 37.9% in the campaign states, but declined slightly in
the comparison states, yielding a relative increase (differ-
ence-in-difference) of 23 percentage points (p = 0.004).
Discussion
In a cluster-randomized trial of a 6-month IHI quality
improvement campaign, we found large increases in ad-
herence to evidence-based practices that can prevent
post-operative infection after hip and knee arthroplasty.
Campaign states improved to a greater extent than non-
campaign states. On measures of the practice of nasal
screening and decolonization, the improvements were sta-
tistically significant in the difference-in-difference ana-
lysis (p < 0.05). On a pre-specified composite of reliable
adoption of the three new evidence-based practice
bundles, we found a statistically significant 23-percentage-
point increase in campaign states relative to non-
campaign states. These findings suggest that the substan-
tial increased use of the three new evidence-based SSI pre-
vention practices included in the bundle was attributable
to the six-month campaign.
Over the past two decades, considerable effort has
been devoted to developing effective methods for rapidly
increasing the use of newly emerging evidence-based
clinical practices and spreading their use across large
numbers of organizations [28]. Most studies have fo-
cused on QI collaboratives and national initiatives that
measure and report performance. These have shown ef-
fectiveness in some non-randomized studies (such as a
statewide collaborative to reduce central-line associated
bloodstream infections and the national D2B Alliance)
[29, 30]. Yet the value of the collaborative approach re-
mains unclear. Systematic reviews of QI collaboratives
suggest that they are effective for some clinical situations
and some settings but may produce modest or no im-
provement in others [3, 31]. Collaboratives can be
Table 4 Change in reported use of evidence-based orthopedic surgery infection control practices in campaign and non-campaign
states before and after the Project JOINTS campaign (italics indicate p<0.05 for the comparison)
Campaign states Non-campaign states Campaign vs.
non-campaign states
(difference-in-difference)
Pre-intervention
n = 77
Post-intervention
n = 74
Pre-intervention
n = 94
Post-intervention
n = 91
% (S.D.) p % (S.D.) p Percentage
point change
p
New evidence-based infection control practices
1. Screening and decolonization
1.a. Pre-operative nasal screening
for Staphylococcus aureus
carriage
49.6 (4.5) 60.2 (4.4) <0.0001 59.0 (4.3) 60.7 (4.2) 0.558 8.8 0.022
1.b. Intranasal mupirocin prescribed
for methicillin- resistant
S. aureus (MRSA) carriers
49.7 (4.3) 65.5 (4.2) <0.0001 71.9 (4.3) 78.0 (4.0) 0.090 9.7 0.042
1.c. Intranasal mupirocin prescribed
for methicillin-sensitive
S. aureus (MSSA) carriers
37.0 (4.7) 55.0 (4.4) <0.0001 52.4 (4.8) 54.5 (4.4) 0.642 15.9 0.008
2. Chlorhexidine bathing 3 or more
times preoperatively
31.1 (4.1) 39.7 (3.8) 0.024 34.1 (4.3) 36.2 (3.9) 0.624 6.5 0.263
3. Alcohol-containing antiseptic
used to prepare skin in
operating room
96.9 (1.2) 99.0 (1.1) 0.019 96.4 (1.2) 96.5 (1.1) 0.863 1.9 0.150
All-or-none composite of the
new evidence-based infection
control practices
19.6 (3.8) 37.9 (5.1) 0.0007 29.1 (4.9) 24.5 (4.3) 0.420 23.0 0.004
Previously promoted infection control practices from the Surgical Care Improvement Program (SCIP)
4. Peri-operative intravenous antibiotics
4.a. Timely receipt of prophylactic
intravenous antibiotics
98.7 (0.6) 99.7 (0.6) 0.027 99.6 (0.6) 98.9 (0.6) 0.230 1.6 0.017
4.b. Intravenous vancomycin
for MRSA
94.8 (1.1) 95.3 (1.1) 0.683 98.0 (1.2) 96.3 (1.2) 0.214 2.2 0.229
5. Appropriate hair removal
techniques
94.2 (1.8) 94.4 (1.6) 0.901 94.8 (1.9) 93.6 (1.6) 0.575 1.4 0.615
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resource intensive, usually involving face-to-face meet-
ings of participants, up to 18-month implementation
periods, and significant staff effort devoted by facilities
that are under significant pressure to reduce costs.
Recent efforts to reduce the duration of projects and
engage participants virtually may address these chal-
lenges, but the effectiveness of “reduced effort” collabo-
ratives is unclear.
The QI campaign is distinct from a collaborative in
several ways. Like a political campaign, an improvement
campaign orchestrates a carefully designed multi-faceted
communications strategy, including tailored customer-
specific messaging (e.g., for clinicians, patients, and ad-
ministrators) and deploys diverse modes of delivery to
engage relevant audiences [32]. A QI campaign is similar
to other QI initiatives with a deliberate focus on a pre-
specified set of evidence-based practices, but in addition,
it leverages both professional and informal social net-
works within and across organizations to inform, motiv-
ate, and support the adoption and use of these practices.
A campaign can take advantage of an established and
potentially reusable dissemination structure (in this case,
the Rapid Spread Network developed during IHI’s
100,000 Lives Campaign) to achieve timely dissemin-
ation of information and outreach to statewide organiza-
tions, hospital leaders, professional staff, and patients. It
offers access to experts with clinical and QI knowledge,
as well as organizations that have achieved superior per-
formance and can inspire and mentor other organiza-
tions. It facilitates peer support and shared learning to
achieve practice change.
QI campaigns do not require in-person meetings or
require participants to collect and report extensive data.
Anecdotally, campaigns seem best for spreading rela-
tively well-defined, reasonably circumscribed clinical
practices that are easy to message and to implement.
Campaigns may be more effective among peer organiza-
tions that communicate actively with one another or
among professions with a more cohesive identity and
more tightly connected social networks. Local organiza-
tions that participate in communities of learning may be
more receptive to campaigns. Until now, campaigns have
been coordinated and driven by a central organization,
but as social media and supporting technology platforms
continue to evolve, the central organization may increas-
ingly rely on a network of interactive, relatively inde-
pendent learning communities in which innovative
approaches to implementing evidence-based practices
can be communicated and spread rapidly.
Few randomized, controlled evaluations of the QI cam-
paign approach have been carried out. In the U.S., National
campaigns, such as the D2B Alliance and the Partnership
for Patients, made the intervention available to all poten-
tial participants, eliminating the option of control groups.
Without control groups, observed improvements due to
other factors may be erroneously attributed to the inter-
vention [33]. In this study, we limited the campaign
to intervention states by limiting publicity outside of the
intervention states, using password-protected websites,
and deferring participation requests from other states
until after the study, when the campaign was released na-
tionally. The lack of improvement in matched control
states suggests that this cluster-randomized evaluation
strategy was successful.
Our study has limitations. First, it is possible, though
unlikely, that other national initiatives might have influ-
enced practice. For example, the Partnership for
Patients—a nationwide federal initiative that included ef-
forts to reduce surgical site infection—was announced
during Project JOINTS. However, we did not see improve-
ment in the adoption of the evidence-based practices in
our control states that were also exposed to the Partner-
ship. Also, in our previously published qualitative research
study, hospital leaders in the intervention states did not
identify other initiatives with impact during the interven-
tion period [13]. Second, in a cluster-randomized design
residual imbalances could lead to differences between
intervention and control states. To address this, we ad-
justed for respondent and organizational factors that dif-
fered between the intervention and control states using
doubly robust multivariable methods. Third, we relied on
staff reports of the use of evidence-based practices, which
may have introduced various forms of reporting bias. The
study design addressed this in several ways. We surveyed
staff in both intervention and control states before and
after the intervention, so if reporting bias were an issue, it
would have to have differed in the campaign and non-
campaign states. The survey avoided direct reference to
the campaign. Our results suggest that staff differentiated
among the bundle components we studied, reporting
high rates of established infection control practices
(i.e., peri-operative antibiotics) and variable use of the
three newer evidence-based practices. Data on
hospital-specific SSI rates would have been useful to
corroborate our results, and those data were not
available to us. Others have reported that use of the
practices Project JOINTS targeted were associated
with reduced infection rates [34].
Our results demonstrate the utility of cluster-
randomized trial designs in assessing the impact of major
improvement initiatives. This evaluation method including
comparison groups and baseline measurements may be
especially important as the Center for Medicare and
Medicaid Innovation (CMMI) is introducing variety of in-
novative quality improvement initiatives in a short time-
frame throughout the U.S. Baseline measures are critical
because many measures may demonstrate variable or very
high rates of adherence before intervention. Further
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improvement may not be possible under such circum-
stances. Finally, our study suggests that evaluation need
not seriously delay implementation of effective interven-
tions. The Project JOINTS campaign was opened to all
states shortly after data collection was completed.
Conclusions
In summary, in a cluster-randomized trial, we found that
a quality improvement campaign increased the use of
evidence-based practices that evidence demonstrates can
reduce surgical site infections in hip and knee arthro-
plasty. We conclude that a carefully crafted campaign can
accelerate the spread of evidence-based practices, scaling
results from clinical trials and promising local initiative to
larger regions and states. Application of the campaign
method may be especially useful when newly emerging
evidence suggests changes to current clinical care should
be adopted rapidly as best practice. Given the substantial
number of new evidence-based practices emerging each
year, the campaign may be an efficient alternative or ad-
junct to other improvement scale-up methods.
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